What is the risk of virus transmission with AlbuRx®?
A. Since the introduction of Albumin over 50 years ago, there have been no confirmed reports of viral transmission. AlbuRx® is pasteurized (heat treatment in aqueous solution) at 60°C for 10 hours. This viral inactivation process has demonstrated elimination of both lipid-enveloped and certain non-lipid-enveloped viruses in validation experiments. As with all plasma-derived products, the risk of transmission of infectious agents, including viruses and theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.